Physics of the Dark Universe
Издатель: Elsevier · ISSN 2212-6864 · 30 статей
-
Rapid UPLC-MS/MS Detection of UTI Pathogen Metabolic Markers for Precision Nursing
Publication date: Available online 24 March 2026 Source: Current Pharmaceutical Analysis Author(s): Ying He, Min Chen, Liu Yu, Ling Weng, Rong Zhang
-
Current Status and Prospects of Microbial Ecology and Detection Strategies in Pharmaceutical Water Systems
Publication date: Available online 3 July 2026 Source: Current Pharmaceutical Analysis Author(s): Shuang Zhou, Yu Wang, Lei Zhang
-
Metabolic Reprogramming in Periodontitis: Evidence Stratification, Pharmacological Modulators, and Translational Challenges
Publication date: Available online 24 September 2026 Source: Current Pharmaceutical Analysis Author(s): Kepan Jia, Ke Wang, Wenyan Zhang, Yongwu Wang
-
Smilax glabra Roxb. alleviates gout through targeting FOS and CD40LG: Insights from multi-omics integration
Publication date: October 2026 Source: Current Pharmaceutical Analysis, Volume 22, Issue 8 Author(s): Hui Zhou, Xiansheng Tian, Kaijie Ye
-
Real-world adverse event signals of immunotherapeutic agents in lung cancer: A pharmacovigilance data mining approach
Publication date: October 2026 Source: Current Pharmaceutical Analysis, Volume 22, Issue 8 Author(s): Jiahui Gao, Xu Lu, Feng Liu
-
Association of bevacizumab added to chemotherapy and whole-brain radiotherapy with peritumoral edema and prognosis in patients with brain metastases from non-squamous non-small cell lung cancer
Publication date: October 2026 Source: Current Pharmaceutical Analysis, Volume 22, Issue 8 Author(s): Jiaxing Sun, Renmin Zhang, Lei Zhang, Yuejiao Zhong, Jiangang Liu
-
A novel stability indicating LC method for simultaneous determination of Vildagliptin and Pioglitazone hydrochloride in API and marketed formulations
Publication date: October 2026 Source: Current Pharmaceutical Analysis, Volume 22, Issue 8 Author(s): Manoj V. Mahale, Ramanlal N. Kachave
-
Quercetin suppresses the malignant phenotypes and epithelial-mesenchymal transition in head and neck squamous cell carcinoma cells by regulating the PI3K/AKT signaling pathway
Publication date: October 2026 Source: Current Pharmaceutical Analysis, Volume 22, Issue 8 Author(s): Pei Zhang, Di Huang, Miaomiao Xue
-
Network pharmacology and molecular docking reveal the active compounds and key targets of JiaWei SiNi San in hepatocellular carcinoma
Publication date: October 2026 Source: Current Pharmaceutical Analysis, Volume 22, Issue 8 Author(s): Fan Zhang, Haojia Wu, Jing Wu, Kun Zhou
-
Novel dichloroacetamide derivatives: Synthesis, cytotoxicity evaluation, molecular docking study, MD simulations, and ADME study
Publication date: October 2026 Source: Current Pharmaceutical Analysis, Volume 22, Issue 8 Author(s): Amirhossein Abbassi, Leila Emami, Mahkameh Moradimehrabadi, Razieh Sabet, Zahra Faghih, Zeinab Faghih, Sahba Ghaffarian, Bahareh...
-
Bioinformatics and artificial intelligence for the discovery of food-derived bioactive compounds with health applications: Current advances and future perspectives
Publication date: October 2026 Source: Current Pharmaceutical Analysis, Volume 22, Issue 8 Author(s): Débora Fernandes Pinheiro, Jéssica Camile Favarin, Cassio Geremia Freire, Natan Veiga, Juliângela Mariane Schröeder Ribeiro dos...
-
Sustainable synthetic strategies for active pharmaceutical ingredients using renewable resources: A systematic review
Publication date: October 2026 Source: Current Pharmaceutical Analysis, Volume 22, Issue 8 Author(s): Vikrant Verma, Rajender S. Varma
-
Refining sedation strategies in elderly patients: A critical analysis of esketamine and propofol combination in gastrointestinal endoscopy
Publication date: October 2026 Source: Current Pharmaceutical Analysis, Volume 22, Issue 8 Author(s): Muhammad Taufan Umasugi, Muhammad Azril Hardiman Mahulauw, Djulfikri Mewar
-
Schisandra lignans in hepatocellular carcinoma: multi-mechanistic insights and translational horizons
Publication date: October 2026 Source: Current Pharmaceutical Analysis, Volume 22, Issue 8 Author(s): Zhiyu Ye, Xinfeng Lu, Wenguan Yu, Ying Du, Yunshou Lin
-
Wnt/β-catenin signaling pathway mediates the inhibitory effects of Liensinine on epithelial-mesenchymal transition, migration, and invasion in non-small cell lung cancer
Publication date: Available online 9 October 2026 Source: Current Pharmaceutical Analysis Author(s): Xiang Ji, Dongyang Xu, Chenxiao Qiao, Xiaoying Zhang, Qingchao Kong, Qiugen Li
-
5-Benzylacyclouridine suppresses malignant phenotypes and aerobic glycolysis in lung adenocarcinoma cells in association with reduced UPP1 expression
Publication date: Available online 10 October 2026 Source: Current Pharmaceutical Analysis Author(s): Jing Yu, Wei Zhang, Luqi Liu, Chenfei Zhang
-
Applications of QSPR polynomial and empirical models for predicting physicochemical properties of pharmaceutically important compounds
Publication date: Available online 15 October 2026 Source: Current Pharmaceutical Analysis Author(s): C V Rao, Habibur Rahman
-
Astragaloside IV Alleviates Peritoneal Dialysis-Related Peritoneal Fibrosis by Regulating HIF-1α-Mediated Autophagy
Publication date: Available online 21 October 2026 Source: Current Pharmaceutical Analysis Author(s): Jinjing Wang, Zixuan Song, Ziyuan Zhang, Yanyan Sun, Yaling Hu, Sufen Li, Wenyuan Liu, Dalin Sun, Yanan Xue, Jingai Fang
-
α-KG activates the OXGR1-Gq-MYL9 axis in VSMC: a potential therapeutic target for rosacea erythema
Publication date: Available online 21 October 2026 Source: Current Pharmaceutical Analysis Author(s): Cong Hu, Longping Li, Jialu Huang, Jin Zou
-
Development and validation of a stability-indicating RP-HPLC method for simultaneous estimation of darunavir ethanolate and ritonavir in tablet dosage form
Publication date: Available online 28 October 2026 Source: Current Pharmaceutical Analysis Author(s): Shubham Ghatole, Santanu Kaity
-
A multi-component, multi-target, multi-pathway study of Er Shen Qing Fei prescription in the treatment of radiation pneumonitis
Publication date: Available online 30 October 2026 Source: Current Pharmaceutical Analysis Author(s): Wenyuan Niu, Gaofeng Hu, Shuming Xie, Yanlin Wang, Zhen Zhang, Yanyang Liu, Huize Shen, Jie Xuan, Junjie Xia, Qiqi Zheng, Zhihao Lin,...
-
Potential cardioprotective mechanisms of Bawu Junzi decoction in myocardial infarction: Identification of CYP1B1 and ALDH2 as key mediators
Publication date: November 2026 Source: Current Pharmaceutical Analysis, Volume 22, Issue 9 Author(s): Fengtong Li, Jingmei Chai
-
In vitro evidence of Piperlongumine as a potential radiosensitizer in cervical cancer cells
Publication date: November 2026 Source: Current Pharmaceutical Analysis, Volume 22, Issue 9 Author(s): Li Shan, Ye Lu, Xiaoli Zhu, Xu Cheng
-
Paeoniflorin alleviates sepsis-induced liver injury: Insights from integrative transcriptomic and metabolomic analysis
Publication date: November 2026 Source: Current Pharmaceutical Analysis, Volume 22, Issue 9 Author(s): Li Li, Xinyu Gu, Hui Wang, Yingru Liu, Lijun Xu, Yanwei Cheng, Lu Wang
-
A comparative bibliometric analysis of natural product-based combination therapies in lung cancer: Insights into analytical strategies and translational challenges
Publication date: November 2026 Source: Current Pharmaceutical Analysis, Volume 22, Issue 9 Author(s): Chuanlong Zhang, Mengqi Gao, Xiyuan Zhang, Chang Che, Xuanye Cao, Lin Zhang, Ziheng Wang
-
Targeting the oncogenic SND1-MTDH interface through drugbank-based virtual screening: structural and electronic insights from molecular docking, molecular dynamics, and DFT analyses
Publication date: November 2026 Source: Current Pharmaceutical Analysis, Volume 22, Issue 9 Author(s): Alaa H.M. Abdelrahman, Dina E.M. Mohamed, Peter A. Sidhom, Mohamed A.A. Attia, Randa R.A. Hemia, Yanshuo Han, Mahmoud A.A. Ibrahim,...
-
MCTR1 attenuates Con A-induced acute immune-mediated liver injury through suppression of oxidative stress, apoptosis, and NLRP3 inflammasome activation
Publication date: November 2026 Source: Current Pharmaceutical Analysis, Volume 22, Issue 9 Author(s): Yinglin Yuan, Yan Chen, Bin Wang, Jingyuan Wan
-
Changyanqing Formula Ameliorates DSS-Induced Colitis by Restoring Intestinal Barrier Function via Mitochondrial Metabolic Reprogramming
Publication date: Available online 4 November 2026 Source: Current Pharmaceutical Analysis Author(s): Wei He, Longling Cong, Hui Zhang, Yunkai Dai, Wei Jiao, Yujin Wu
-
Structure-based virtual high-throughput screening and molecular dynamics simulations for repurposing FDA-approved drugs as STAT3 inhibitors
Publication date: Available online 12 November 2026 Source: Current Pharmaceutical Analysis Author(s): Guangshuai Zhang, Yingyan Liao, Ziyu Tan, Qingqing Xie, Zishu Liu, Jin Xiao, Si Yan, Xiaoqian Guo, Rui Peng, Wei Luo, Shuanglin Qin
-
Two Drugs, Distinct Profiles, One Goal: Individualised Treatment of MASH
Publication date: Available online 13 November 2026 Source: Current Pharmaceutical Analysis Author(s): Amedeo Lonardo, Ralf Weiskirchen